X-103310427-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032621.4(BEX2):c.-75G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,155,752 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000035 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.0000086 ( 0 hom. 4 hem. )
Consequence
BEX2
NM_032621.4 5_prime_UTR
NM_032621.4 5_prime_UTR
Scores
2
12
Clinical Significance
Conservation
PhyloP100: 0.0380
Genes affected
BEX2 (HGNC:30933): (brain expressed X-linked 2) This gene belongs to the brain expressed X-linked gene family. The encoded protein interacts with the transcription factor LIM domain only 2 in a DNA-binding complex that recognizes the E-box element and promotes transcription. This gene has been found to be a tumor suppressor that is silenced in human glioma. In breast cancer cells, this gene product modulates apoptosis in response to estrogen and tamoxifen, and enhances the anti-proliferative effect of tamoxifen. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09188634).
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BEX2 | NM_032621.4 | c.-75G>C | 5_prime_UTR_variant | 2/3 | ENST00000372677.8 | ||
BEX2 | NM_001168399.2 | c.22G>C | p.Gly8Arg | missense_variant | 2/3 | ||
BEX2 | NM_001168400.2 | c.19G>C | p.Gly7Arg | missense_variant | 2/3 | ||
BEX2 | NM_001168401.2 | c.-75G>C | 5_prime_UTR_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BEX2 | ENST00000372677.8 | c.-75G>C | 5_prime_UTR_variant | 2/3 | 1 | NM_032621.4 | P1 | ||
BEX2 | ENST00000536889.1 | c.22G>C | p.Gly8Arg | missense_variant | 2/3 | 2 | |||
BEX2 | ENST00000372674.5 | c.-75G>C | 5_prime_UTR_variant | 2/3 | 2 | P1 | |||
BEX2 | ENST00000449185.1 | c.-75G>C | 5_prime_UTR_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000354 AC: 4AN: 112854Hom.: 0 Cov.: 23 AF XY: 0.0000571 AC XY: 2AN XY: 35004
GnomAD3 genomes
AF:
AC:
4
AN:
112854
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
35004
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000194 AC: 2AN: 103030Hom.: 0 AF XY: 0.0000268 AC XY: 1AN XY: 37244
GnomAD3 exomes
AF:
AC:
2
AN:
103030
Hom.:
AF XY:
AC XY:
1
AN XY:
37244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000863 AC: 9AN: 1042898Hom.: 0 Cov.: 31 AF XY: 0.0000117 AC XY: 4AN XY: 341414
GnomAD4 exome
AF:
AC:
9
AN:
1042898
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
341414
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000354 AC: 4AN: 112854Hom.: 0 Cov.: 23 AF XY: 0.0000571 AC XY: 2AN XY: 35004
GnomAD4 genome
AF:
AC:
4
AN:
112854
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
35004
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.22G>C (p.G8R) alteration is located in exon 2 (coding exon 2) of the BEX2 gene. This alteration results from a G to C substitution at nucleotide position 22, causing the glycine (G) at amino acid position 8 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
T
Vest4
MutPred
Gain of sheet (P = 0.0221);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at